Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LATTICE: Lithium for MCI
NCT03185208Phase 4Completed
- Start
- Feb 2018
- Primary completion
- Aug 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium carbonate in Mild Cognitive Impairment (MCI). Started Feb 2018; status: completed.
02
Drugs
lithium carbonate
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT03185208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03185208.